Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 15;127(4):619-627.
doi: 10.1002/cncr.33315. Epub 2020 Nov 10.

Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancer

Emily E van Seventer  1 , Madeleine G Fish  1 , Kathryn Fosbenner  1 , Katie Kanter  1 , Amirkasra Mojtahed  2 , Jill N Allen  1 , Lawrence Blaszkowsky  1 , Jeffrey W Clark  1 , Jon Dubois  1 , Joseph W Franses  1 , Bruce J Giantonio  1 , Lipika Goyal  1 , Samuel J Klempner  1 , Eric J Roeland  1 , David P Ryan  1 , Colin D Weekes  1 , Therese Mulvey  1 , Areej El-Jawahri  1 , Nora Horick  3 , Ryan B Corcoran  1 , Aparna R Parikh  1 , Ryan D Nipp  1
Affiliations
Free article

Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancer

Emily E van Seventer et al. Cancer. .
Free article

Abstract

Background: Patient-reported outcomes (PROs) assessing quality of life (QOL) and symptom burden correlate with clinical outcomes in patients with cancer. However, to the authors' knowledge, data regarding associations between PROs and treatment response are lacking.

Methods: The authors prospectively approached consecutive patients with advanced gastrointestinal cancer who were initiating a new treatment. Prior to treatment, patients reported their QOL (Functional Assessment of Cancer Therapy-General [FACT-G], 4 subscales: Functional, Physical, Emotional, Social; higher scores indicate better QOL) and symptom burden (Edmonton Symptom Assessment System [ESAS], Patient Health Questionnaire-4 [PHQ-4]; higher scores represent greater symptoms). Regression models were used to examine associations of baseline PROs with treatment response (clinical benefit or progressive disease [PD] at time of first scan), healthcare utilization, and survival.

Results: From May 2019 to April 2020, a total of 112 patients with advanced gastrointestinal cancer were enrolled. For treatment response, 64.3% had CB and 35.7% had PD. Higher baseline ESAS-Physical (odds ratio, 1.04; P = .027) and lower FACT-G Functional (odds ratio, 0.92; P = .038) scores were associated with PD. Higher ESAS-Physical (hazard ratio [HR], 1.03; P = .044) and lower FACT-G Total (HR, 0.96; P = .005), FACT-G Physical (HR, 0.89; P < .001), and FACT-G Functional (HR, 0.87; P < .001) scores were associated with a greater hospitalization risk. Lower FACT-G Total (HR, 0.96; P = .009) and FACT-G Emotional (HR, 0.86; P = .012) scores as well as higher ESAS-Total (HR, 1.03; P = .014) and ESAS-Physical (HR, 1.04; P = .032) scores were associated with worse survival.

Conclusions: Baseline PROs are associated with treatment response in patients with advanced gastrointestinal cancer, namely physical symptoms and functional QOL, in addition to health care use and survival. The findings of the current study support the association between PROs and important clinical outcomes, including the novel finding of treatment response.

Keywords: health care use; quality of life; survival; symptoms; treatment response.

PubMed Disclaimer

References

    1. Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin. 2007;57:278-300. doi:10.3322/ca.57.5.278
    1. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer. 2002;38:1351-1357. doi:10.1016/S0959-8049(02)00098-9
    1. Pirl WF, Greer JA, Traeger L, et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012;30:1310-1315. doi:10.1200/JCO.2011.38.3166
    1. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34:94-104. doi:10.1016/j.jpainsymman.2006.10.015
    1. Stukenborg GJ, Blackhall LJ, Harrison JH, Dillon PM, Read PW. Longitudinal patterns of cancer patient reported outcomes in end of life care predict survival. Support Care Cancer. 2016;24:2217-2224. doi:10.1007/s00520-015-3024-y

Publication types

LinkOut - more resources